Overexpression of soluble Fas attenuates transplant arteriosclerosis in rat aortic allografts

被引:25
作者
Wang, T
Dong, CM
Stevenson, SC
Herderick, EE
Marshall-Neff, J
Vasudevan, SS
Moldovan, NI
Michler, RE
Movva, NR
Goldschmidt-Clermont, PJ
机构
[1] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA
[2] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Dept Biomed Engn, Columbus, OH 43210 USA
[3] Genet Therapy Inc, Gaithersburg, MD USA
[4] Novartis, Transplantat Dept, Basel, Switzerland
关键词
arteriosclerosis; apoptosis; endothelium; inflammation; gene therapy;
D O I
10.1161/01.CIR.0000027822.23269.07
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The killing of vascular cells by activated macrophages is an important stop in the process of destabilization of the arterial wall. The death receptor Fas is implicated in vascular cell death. Hence, we extended our studies in a rat aortic allograft model, using adenovirus-mediated overexpression of soluble Fas (sFas) to block Fas binding to Fas ligand (Fas-L). The contribution of Fas to vascular cell injury and consequent transplant arteriosclerosis was investigated. Methods and Results-Activated monocytes in the presence of macrophage colony-stimulating factor induce endothelial cell apoptosis in vitro, which was significantly inhibited by adenovirus-mediated sFas overexpression. Next, donor rat abdominal aortas were either untreated or transduced with adenoviruses encoding (1) rat soluble Fas (Ad3rsFas), (2) no insert (Ad3Null), and (3) beta-galactosidase (Ad3nBg). A total of 175 aortic grafts were harvested 2 to 90 days after transplantation. Vascular cell apoptosis and CD45 + cell infiltration were significantly reduced in Ad3rsFas-transduced aortas, as compared with control allografts. Moreover, the control allografts developed marked intimal thickening, whereas Ad3rsFas-transduced allografts had significantly less neointima until the 90-day time point. Conclusions-sFas overexpression protects the integrity of the vessel wall from immune injury and attenuates transplant arteriosclerosis.
引用
收藏
页码:1536 / 1542
页数:7
相关论文
共 32 条
[1]   Tolerance induction ameliorates allograft vasculopathy in rat aortic transplants -: Influence of Fas-mediated apoptosis [J].
Akyürek, LM ;
Johnsson, C ;
Lange, D ;
Georgii-Hemming, P ;
Larsson, E ;
Fellström, BC ;
Funa, K ;
Tufveson, G .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (12) :2889-2899
[2]   Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts [J].
Allison, J ;
Georgiou, HM ;
Strasser, A ;
Vaux, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :3943-3947
[3]   A ROLE FOR CD95 LIGAND IN PREVENTING GRAFT-REJECTION [J].
BELLGRAU, D ;
GOLD, D ;
SELAWRY, H ;
MOORE, J ;
FRANZUSOFF, A ;
DUKE, RC .
NATURE, 1995, 377 (6550) :630-632
[4]   THE EFFECTS OF COLONY-STIMULATING FACTORS ON HUMAN MONOCYTE CELL-FUNCTION [J].
BOBER, LA ;
GRACE, MJ ;
PUGLIESESIVO, C ;
ROJASTRIANA, A ;
SULLIVAN, LM ;
NARULA, SK .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1995, 17 (05) :385-392
[5]   Human blood-derived macrophages induce apoptosis in human plaque-derived vascular smooth muscle cells by Fass-ligand/Fas interactions [J].
Boyle, JJ ;
Bowyer, DE ;
Weissberg, PL ;
Bennett, MR .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (09) :1402-1407
[6]  
Cascino Isabella, 1996, Frontiers in Bioscience (online), V1, pD12
[7]   Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant [J].
Davis, SF ;
Yeung, AC ;
Meredith, IT ;
Charbonneau, F ;
Ganz, P ;
Selwyn, AP ;
Anderson, TJ .
CIRCULATION, 1996, 93 (03) :457-462
[8]   T-cell and monocyte subsets, inflammatory molecules, rejection, and hemodynamics early after cardiac transplantation [J].
Deng, MC ;
Erren, M ;
Roeder, N ;
Dreimann, V ;
Günther, F ;
Kerber, S ;
Baba, HA ;
Schmidt, C ;
Breithardt, G ;
Scheld, HH .
TRANSPLANTATION, 1998, 65 (09) :1255-1261
[9]  
Dong CM, 1996, LAB INVEST, V74, P921
[10]  
Donnelly LH, 1997, MOL REPROD DEV, V46, P92, DOI 10.1002/(SICI)1098-2795(199701)46:1<92::AID-MRD14>3.0.CO